Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection

Pisano, María Belén; Blanco, Sebastián; Carrizo, Horacio; Ré, Viviana Elizabeth; Gallego, Sandra

doi:10.1007/s00705-016-2960-2

Cited by 10 publications

(14 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a recent publication of our group, an OBI prevalence of one in 17,525 (4/70,102) based on virologic and serologic profiles at time of donation was reported for some donors that are included in this study. Complementary serologic assays and follow‐up performed of donors with suspected OBI allowed us a better characterization of these infections and to define a rate of OBIs detected by NAT in a larger casuistry as 1.8 in 100,000 donors (3/168,215).…”

Section: Discussionmentioning

confidence: 99%

Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion‐transmitted infection in Argentina: high rate of recent infections

Blanco

Balangero

Valle³

et al. 2016

Transfusion

Self Cite

View full text Add to dashboard Cite

NAT contributed significantly to the reduction of the potential risk of HBV transmission with a frequency of one in 56,072, detecting three in 168,215 donors without serologic evidence of infection. NAT also detected three in 168,215 OBIs. The finding of high frequency of recent infections (1/33,643), unexpected for this country, highlights the need of promoting unified effective regulations that enforce the use of NAT in all blood banks in Argentina and points out the importance of assessing the risk of HBV transmission in blood banks of other countries considered to be low-endemic.

show abstract

Section: Discussionmentioning

confidence: 99%

Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion‐transmitted infection in Argentina: high rate of recent infections

Blanco

Balangero

Valle³

et al. 2016

Transfusion

Self Cite

View full text Add to dashboard Cite

show abstract

“…However, the data on the study of blood donors, stem cells, and organs for the presence of OHB are little and contradictory. For example, among blood donors in Argentina (n = 70 102), HBV was detected in only 0.06% of the samples, of which only four were OHB [35]. In the Lao People's Democratic Republic, the prevalence of OHB among HBsAg-negative blood donors was 10.9% [23].…”

Section: Resultsmentioning

confidence: 98%

“…In the Lao People's Democratic Republic, the prevalence of OHB among HBsAg-negative blood donors was 10.9% [23]. In Nigeria, the incidence of OHB among blood donors reached 17% [35]. In the analysis of healthy stem cell donors from South Korea, OHB was detected in 15.3%, which, like in the case of a significant occurrence of OHB in the population, can be explained by the high prevalence of hepatotropic viruses in this geographic region [20].…”

Section: Resultsmentioning

confidence: 99%

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN

Ostankova

Семенов

Буркитбаев

et al. 2018

Russian Journal of Infection and Immunity

View full text Add to dashboard Cite

Abstract. The prevalence of HBV infection is estimated by the frequency of occurrence of HBsAg and varies depending on the geographic region. Chronic infection is characterized by a stable presence of HBsAg for 6 months, with the exception of the occult form of the disease, characterized by the absence of HBsAg, an extremely low level of HBV DNA in the blood serum. The problem of identifying occult HBV (ocHBV) is especially relevant because of the development of transplantology and transfusiology. However, serological screening of donor blood used in the Russian Federation and Central Asian countries does not reveal HBV seronegative donors. Since HBV infection is possible with the introduction of small doses of the virus, the importance of using complex molecular methods for detecting donor ocHBV is obvious, despite the low viral load, since donor blood is used predominantly in patients with severe course of various diseases characterized by increased susceptibility to HBV because of immunosuppression. The aim of our work was to study the characteristics of the genetic structure of the ocHBV in donors in Astana, Kazakhstan. A total of 500 blood plasma samples from HBsAg-negative donors were obtained in 2012 from residents of Kazakhstan, Astana. Using the method, we proposed to detect HBV DNA with a low viral load, HBV was detected in 9.4% of donors. Serological markers were found in 12.7% of patients with HBV DNA, 8.5% had HBcor IgG antibodies, 4.2% had HBcor IgG and HBe IgG antibodies at the same time. Thus, in 41 (87.3%) of the blood donor, ocHBV was seronegative. Based on the phylogenetic analysis of the 47 isolates showed that the HBV of genotype D (95.75%) prevails in the examined group in comparison with HBV of genotype A (4.25%). HBV subgenotypes are represented in the following ratios: D1 -46.8%, D2 -17.05%, D3 -31.9%, A2 -4.25%. In a comparative analysis, the distribution of HBV subgenotypes in the group with ocHBV and in the case of the manifest form in donors in the Republic of Kazakhstan significantly differed -χ 2 = 14.027 at p = 0.0072, d f = 4. The incidence of HBV D3 with ocHBV (31.9%) exceeded that of patients with a manifest form (7.4%). The relative risk of occult form of disease in patients with the subgenotype D3 is significantly higher (RR = 1.572, CI: 1.179-2.096, p = 0.0208). When assessing the picture of HBV diversity on the material of the group including HBsAg-negative and HBsAg-positive blood donors, it is evident that the genetic relationship of the manifestations of the manifest HBV and the ocHBV of genotype D is obvious. Among the isolates are both similar in nucleotide sequences with those previously described in various regions of Europe and Central Asia, and circulating in the territory of the Republic of Kazakhstan, which indicates an independent homologous evolution of HBV in the region. The high incidence of ocHBV among HBsAg-negative blood donors is indicative not only of the widespread prevalence of the occult form of the disease course in the population and the inadequacy ...

show abstract

“…The "anti-HBc" serological status could be attributed to different parameters among which are: (a) passive transfer of anti-HBc; (b) a recent HBV infection during which HBsAg has disappeared, while anti-HBs levels are yet undetectable; or (c) chronic HBV infection during which HBsAg is undetectable due to very low viraemia, a clinical phase recognized as occult HBV infection (14)(15)(16)(17). Although many countries implement an anti-HBc test before blood transfusion, in an attempt to decrease the risk of HBV transmission, recent studies (18)(19)(20) clearly demonstrated an absence of correlation between anti-HBc positivity and presence of HBV-DNA, indicating that anti-HBc screening is not a recommended method to identify HBV infection. For instance, a donor showing positivity for anti-HBc may be a naïve-HBV carrier i.e.…”

Section: Discussionmentioning

confidence: 99%

Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies

et al. 2017

View full text Add to dashboard Cite

show abstract

Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection

Cited by 10 publications

References 21 publications

Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion‐transmitted infection in Argentina: high rate of recent infections

Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion‐transmitted infection in Argentina: high rate of recent infections

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN

Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies

Contact Info

Product

Resources

About